查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679387

医药合约销售组织市场规模、份额、趋势分析报告：按服务、治疗领域、最终用途、地区、细分市场预测，2025-2030 年

Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services (Personal, Non-personal Promotion), By Therapeutic Area, By End Use (Pharma, Biopharma Companies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

医药合约组织市场的成长与趋势

根据 Grand View Research, Inc. 的新报告，全球医药合约销售组织市场规模预计到 2030 年将达到 181.4 亿美元，2025 年至 2030 年的复合年增长率为 8.83%。

合约销售组织（CSO）对合约销售新技术的采用率高、最终用户对扩大生物製药和小分子药物销售的兴趣日益浓厚、降低自我销售相关成本的需求激增是支持该行业增长的一些关键因素。近年来，新药上市的数量不断增加。

例如，根据IQVIA的研发趋势报告，2021年全球将推出84种新的活性物质，较前五年增加一倍。预计全球新药上市数量的增加将推动合约销售服务的需求，这可能会支持该行业的成长。处方药销售额一直在稳定成长。例如，根据Evaluate Pharma的预测，2021年全球处方药销售额将达到1.66兆美元，到2028年将达到1.612兆美元。预计疫情后製药公司销售需求的增加将带动对製药CSO服务的需求增加。

医药合约组织市场报告重点

  • 按服务划分，个人推广领域将在 2024 年占据产业主导地位。预计製药公司研发活动的活性化将导致新药上市和核准数量的增加，从而推动该领域的成长。
  • 由于製药公司在销售产品方面的激烈竞争，推动了对高效团队支援销售活动的需求，预计到 2024 年，医药终端用途领域将占据最大的收益占有率。
  • 2024年，北美将占据最大的收益占有率。过去几年，该地区，尤其是在美国，推出了大量药物，这是支持该地区成长的关键因素之一。
  • 此外，该地区的公共组织也持续增加资金投入，并支持研发活动。这进一步支持了该地区的发展。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章：医药合约销售组织市场：依服务估算与趋势分析

  • 细分仪表板
  • 医药销售合约组织市场、服务波动分析
  • 医药合约销售组织市场规模与趋势分析（按服务），2018 年至 2030 年
  • 个人晋升
    • 推广销售团队
    • 大客户管理
    • 空缺管理
  • 非个人推广
    • 医疗解决方案
    • 远端医疗科学联络
    • 护理教育者
    • 其他的

第五章：医药销售合约组织市场：依治疗领域进行的估计与趋势分析

  • 细分仪表板
  • 医药合约销售组织市场、治疗领域变化分析
  • 2018-2030 年医药合约销售组织市场规模及趋势分析（依治疗领域）
  • 肿瘤学
  • 心血管
  • 神经病学
  • 感染疾病
  • 代谢紊乱
  • 整形外科疾病
  • 其他的

第六章 医药合约组织市场：依最终用途的估计和趋势分析

  • 细分仪表板
  • 医药合约组织市场、最终用途趋势分析
  • 2018 年至 2030 年医药合约销售组织规模及趋势分析（依最终用途）
  • 製药公司
  • 生物製药公司

第七章区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 2018-2030年北美製药合约组织市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲製药合约组织市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区医药合约分销组织市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲医药合约销售组织市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲医药合约分销组织市场（2018-2030）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 公司分类
  • 2024年企业市场分析
  • 公司简介
    • CMIC Holdings Co., Ltd.
    • Axxelus
    • EPS Corp.
    • QFR Solutions
    • MaBico
    • Mednext Pharma Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • IQVIA, Inc.
    • Promoveo Health
    • Syneous Health
Product Code: GVR-4-68040-034-7

Pharmaceutical Contract Sales Organizations Market Growth & Trends:

The global pharmaceutical contract sales organizations market size is estimated to reach USD 18.14 billion by 2030, expanding at a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry. Over the years, the number of new drug launches has increased.

For instance, according to the IQVIA report on R&D trends, 84 new active substances were launched globally in 2021, which was double as compared to the last five years. The increase in drug launches globally is expected to improve the demand for contract sales services, which is likely to support industry growth. Prescription drug sales are witnessing a steady rise. For instance, according to Evaluate Pharma, worldwide total prescription drug sales accounted for USD 1,066 billion in 2021 and will reach USD 1,612 billion by 2028. The growing demand for sales among pharmaceutical companies is expected to improve the demand for CSO services for pharmaceuticals in the post-pandemic period.

Pharmaceutical Contract Sales Organizations Market Report Highlights:

  • Based on service, the personal promotion segment dominated the industry in 2024. A rise in the R&D activities of pharmaceutical companies is expected to increase the number of new drug launches, and approvals are expected to support the segment growth
  • The pharmaceutical companies end-use segment held the largest revenue share in 2024 due to the high competition among pharmaceutical companies in product sales, promoting the demand for an efficient team to support their sales activities
  • North America held the largest revenue share in 2024. A significant number of drugs were launched in the region in the previous years, especially in the U.S., which is one of the key factors supporting the region's growth
  • Moreover, the region's public organization is steadily focused on supporting R&D activities by providing funding. This has further supported the region's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Contract Sales Organizations Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pharmaceutical Contract Sales Organizations Market; Service Movement Analysis
  • 4.3. Pharmaceutical Contract Sales Organizations Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Personal Promotion
    • 4.4.1. Personal promotion market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Promotional sales team
      • 4.4.2.1. Promotional sales team market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Key account management
      • 4.4.3.1. Key account management market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Vacancy management
      • 4.4.4.1. Vacancy management market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Non-personal promotion
    • 4.5.1. Non-personal promotion market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Medical affairs solutions
      • 4.5.2.1. Medical affairs solutions market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Remote medical science liaisons
      • 4.5.3.1. Remote medical science liaisons market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Nurse educators
      • 4.5.4.1. Nurse educators market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pharmaceutical Contract Sales Organizations Market; Therapeutic Areas Movement Analysis
  • 5.3. Pharmaceutical Contract Sales Organizations Market Size & Trend Analysis, by Therapeutic Areas, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cardiovascular
    • 5.5.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Neurology
    • 5.6.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Infectious Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Metabolic Disorders
    • 5.8.1. Metabolic Disorders market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Orthopedic Diseases
    • 5.9.1. Orthopedic Diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Sales Organizations Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pharmaceutical Contract Sales Organizations Market; End Use Movement Analysis
  • 6.3. Pharmaceutical Contract Sales Organizations Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Biopharmaceutical Companies
    • 6.5.1. Biopharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Germany pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. UK pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. South Korea pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait pharmaceutical contract sales organizations market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. CMIC Holdings Co., Ltd.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Axxelus
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. EPS Corp.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. QFR Solutions
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MaBico
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Mednext Pharma Pvt. Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Peak Pharma Solutions Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. IQVIA, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Promoveo Health
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Syneous Health
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Contract Sales Organizations Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 10 North America Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 13 U.S. Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 Canada Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 16 Canada Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Mexico Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 19 Mexico Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 23 Europe Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 UK Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 25 UK Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 26 UK Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Germany Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Germany Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 29 Germany Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 31 France Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 32 France Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 34 Italy Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 35 Italy Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 Spain Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 38 Spain Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 40 Denmark Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 41 Denmark Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Sweden Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 44 Sweden Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 Norway Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 47 Norway Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 54 Japan Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 China Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 China Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 57 China Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 India Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 60 India Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Australia Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 Australia Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 63 Australia Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 65 South Korea Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 66 South Korea Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Thailand Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 69 Thailand Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 72 Latin America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 73 Latin America Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 75 Brazil Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 76 Brazil Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 78 Argentina Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 79 Argentina Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 80 MEA Pharmaceutical Contract Sales Organizations Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 82 MEA Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 83 South Africa Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 South Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 85 South Africa Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 90 UAE Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 91 UAE Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Pharmaceutical Contract Sales Organizations Market, by Service, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Pharmaceutical Contract Sales Organizations Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Pharmaceutical Contract Sales Organizations Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Contract Sales Organizations Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Pharmaceutical Contract Sales Organizations Market: Service Key Takeaways
  • Fig. 14 Global Pharmaceutical Contract Sales Organizations Market: Service Movement Analysis
  • Fig. 15 Global Pharmaceutical Contract Sales Organizations Market, for Personal Promotion, 2018 - 2030 (USD Million)
  • Fig. 16 Global Pharmaceutical Contract Sales Organizations Market, for Promotional sales team, 2018 - 2030 (USD Million)
  • Fig. 17 Global Pharmaceutical Contract Sales Organizations Market, for Key account management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Pharmaceutical Contract Sales Organizations Market, for Vacancy Management, 2018 - 2030 (USD Million)
  • Fig. 19 Global Pharmaceutical Contract Sales Organizations Market, for Non-personal promotion, 2018 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceutical Contract Sales Organizations Market, for Medical affairs solutions, 2018 - 2030 (USD Million)
  • Fig. 21 Global Pharmaceutical Contract Sales Organizations Market, for Remote medical science liaisons, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pharmaceutical Contract Sales Organizations Market, for Nurse educators, 2018 - 2030 (USD Million)
  • Fig. 23 Global Pharmaceutical Contract Sales Organizations Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Key Takeaways
  • Fig. 25 Global Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Movement Analysis
  • Fig. 26 Global Pharmaceutical Contract Sales Organizations Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pharmaceutical Contract Sales Organizations Market, for Cardiovascular, 2018 - 2030 (USD Million)
  • Fig. 28 Global Pharmaceutical Contract Sales Organizations Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 29 Global Pharmaceutical Contract Sales Organizations Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 30 Global Pharmaceutical Contract Sales Organizations Market, for Metabolic Disorders, 2018 - 2030 (USD Million)
  • Fig. 31 Global Pharmaceutical Contract Sales Organizations Market, for Orthopedic Diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Pharmaceutical Contract Sales Organizations Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Pharmaceutical Contract Sales Organizations Market: End Use Key Takeaways
  • Fig. 34 Global Pharmaceutical Contract Sales Organizations Market, End Use Movement Analysis
  • Fig. 35 Global Pharmaceutical Contract Sales Organizations Market, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global Pharmaceutical Contract Sales Organizations Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 Regional Outlook, 2024 & 2030
  • Fig. 39 North America Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Pharmaceutical Contract Sales Organizations Market, 2018 - 2030 (USD Million)